Century Therapeutics, Inc.
IPSC
$0.52
-$0.0018-0.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -36.07M | -31.22M | -31.21M | -28.06M | -39.40M |
| Total Depreciation and Amortization | 3.32M | 3.30M | 3.46M | 3.23M | 3.55M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 7.66M | 1.41M | -300.00K | 3.63M | 12.53M |
| Change in Net Operating Assets | 871.00K | -1.82M | 713.00K | -9.05M | -2.91M |
| Cash from Operations | -24.22M | -28.33M | -27.33M | -30.25M | -26.23M |
| Capital Expenditure | -154.00K | 804.00K | -265.00K | -539.00K | -980.00K |
| Sale of Property, Plant, and Equipment | -21.00K | 21.00K | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -9.61M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.78M | 38.37M | -23.99M | 12.08M | 19.58M |
| Cash from Investing | 30.61M | 39.20M | -33.86M | 11.54M | 18.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | -- | 74.70M | 104.00K | 366.00K | -- |
| Repurchase of Common Stock | -602.00K | -- | -- | -- | -356.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -74.42M | 56.59M | 17.83M | -- |
| Cash from Financing | -602.00K | 273.00K | 56.70M | 18.20M | -356.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.78M | 11.14M | -4.50M | -512.00K | -7.98M |